Breaking News | YHLO Achieves Full IVDR CE Certification for the Blood Bank Panel 🎉— the First in China 🇨🇳🌍
Breaking News!!! We are thrilled to share a major milestone in YHLO's global regulatory journey that we have got the latest Class D IVDR CE certificate for our HIV assay! With this approval, YHLO has now achieved full IVDR CE certification for the entire Blood Bank Panel—including HIV, HBV(HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc), HCV, and Syphilis(Anti-TP).
This achievement makes YHLO the first company in China — and among the first globally — to obtain full IVDR CE certification for the Blood Bank panel.
Founded in 2008, YHLO is a national high-tech enterprise and specialized in R&D, production and sale of in vitro diagnostic (IVD) instruments and reagents. With our committed innovation, nowadays our multiple products have entered more than 120 countries.
YHLO will continue working hand-in-hand with glogal partners to build a healthier, better future together.
Attachments:
Previous
MORE NEWS
YHLO Joins BSI’s 125th Anniversary Gala in London
On April 23, YHLO Founder Mr. Hu Deming and Chairman Mr. Hu Kunhui attended BSI's 125th anniversary gala in London as the only Chinese IVD representatives.
2026-04-28
Meet YHLO PIFI: Smarter Islet Function Assessment
Launched on April 10 at the 2026 Islet Metabolism Forum in Nanjing, the YHLO PIFI Intelligent Computing Model marks a major step forward in diabetes care.
2026-04-14
2026 YHLO Global Partners Conference: Intelligent Automation · Infinite Potential
On March 30, 2026, YHLO Global Partners Conference was grandly held in Changsha.
2026-04-03
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
